A critical discovery in cancer study is emerging with the use of VHH fragments to reactivate mutated p53. This essential tumor inhibitor protein is frequently disabled in several types of malignancies, resulting https://letsbookmarkit.com/story21923982/nanobodies-reactivate-p53-a-new-hope-for-cancer-treatment